JP2021534489A - 消費者の喫煙習慣の変化を促進するためのシステムおよび方法 - Google Patents
消費者の喫煙習慣の変化を促進するためのシステムおよび方法 Download PDFInfo
- Publication number
- JP2021534489A JP2021534489A JP2021507470A JP2021507470A JP2021534489A JP 2021534489 A JP2021534489 A JP 2021534489A JP 2021507470 A JP2021507470 A JP 2021507470A JP 2021507470 A JP2021507470 A JP 2021507470A JP 2021534489 A JP2021534489 A JP 2021534489A
- Authority
- JP
- Japan
- Prior art keywords
- customer
- level
- data
- toxic
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000391 smoking effect Effects 0.000 title claims description 61
- 238000000034 method Methods 0.000 title claims description 12
- 238000012360 testing method Methods 0.000 claims abstract description 98
- 231100000331 toxic Toxicity 0.000 claims abstract description 56
- 230000002588 toxic effect Effects 0.000 claims abstract description 56
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 53
- 238000012545 processing Methods 0.000 claims abstract description 34
- 239000003440 toxic substance Substances 0.000 claims abstract description 17
- 231100000041 toxicology testing Toxicity 0.000 claims abstract description 15
- 231100000167 toxic agent Toxicity 0.000 claims abstract description 14
- 241000208125 Nicotiana Species 0.000 claims abstract description 10
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 10
- 238000013479 data entry Methods 0.000 claims abstract description 7
- 231100000027 toxicology Toxicity 0.000 claims abstract description 7
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 74
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 74
- 235000019505 tobacco product Nutrition 0.000 claims description 31
- 231100000614 poison Toxicity 0.000 claims description 19
- 239000002574 poison Substances 0.000 claims description 15
- 231100000820 toxicity test Toxicity 0.000 claims description 8
- 238000009602 toxicology test Methods 0.000 claims description 8
- 230000005586 smoking cessation Effects 0.000 claims description 7
- 238000009534 blood test Methods 0.000 claims description 3
- 238000010586 diagram Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000006399 behavior Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0278—Product appraisal
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/60—Devices with integrated user interfaces
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/65—Devices with integrated communication means, e.g. wireless communication means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4845—Toxicology, e.g. by detection of alcohol, drug or toxic products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
- G01N33/4975—Physical analysis of biological material of gaseous biological material, e.g. breath other than oxygen, carbon dioxide or alcohol, e.g. organic vapours
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/26—Visual data mining; Browsing structured data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0281—Customer communication at a business location, e.g. providing product or service information, consulting
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Business, Economics & Management (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Development Economics (AREA)
- Strategic Management (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Theoretical Computer Science (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Economics (AREA)
- Marketing (AREA)
- Game Theory and Decision Science (AREA)
- Entrepreneurship & Innovation (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Veterinary Medicine (AREA)
- Ecology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
Abstract
Description
少なくとも二つの小売店のネットワークの一部を形成する第一の小売店で、顧客の毒物の初期レベルを測定することと、
測定された毒性の初期レベルのデータを顧客識別子とともに、中央サーバーに保存されたデータベースに送信することと、
測定された毒性の初期レベルを顧客に表示することと、
加熱式たばこ製品または電子喫煙装置を顧客に提供することと、
加熱式たばこ製品または電子喫煙装置の一定期間の使用後に、顧客の毒物の新しいレベルを測定することと、
データベースから毒物の初期レベルを受信することと、
毒物の新しいレベルと毒物の初期レベルの比較を顧客に表示することと、
を含む。
Claims (13)
- 加熱式たばこ装置など、従来の紙巻たばこの代替物を提供する小売店のネットワークであって、前記小売店ネットワークが、個々の小売店のそれぞれが異なる場所に位置する二つ以上の個々の小売店と、
顧客データを保存する中央データベースをホストするように構成された中央サーバーであって、個々の小売店のそれぞれが前記中央サーバーに接続されている、中央サーバーと、を備え、
前記小売店ネットワーク中の個々の小売店のそれぞれが毒物試験ステーションを備え、前記毒物試験ステーションが、
顧客の毒物のレベルを検出するための少なくとも一つの毒物試験装置と、顧客情報を受信するように構成されたデータ入力装置と、
前記毒物試験装置に接続された、かつ前記中央サーバーとの間でデータを送受信するように構成された処理装置であって、そのデータが顧客情報データおよび毒物レベルデータを含む処理装置と、
前記処理装置に接続された表示装置と、を備え、前記処理装置が、前記顧客の以前の試験結果と比較して、または集団内の前記毒物の平均レベルと比較して、前記毒物試験装置によって検出された前記毒物レベルのグラフ表示を前記表示装置に提供するように構成されている、小売店のネットワーク。 - 前記毒物試験装置が、顧客が中に息を吐き出す呼気試験装置であり、前記毒物試験ステーションが前記毒物試験装置用の複数の使い捨てマウスピースを備える、請求項1に記載の小売店ネットワーク。
- 前記毒物試験装置が血液試験装置である、請求項1に記載の小売店ネットワーク。
- 前記毒物が一酸化炭素である、請求項1〜3のいずれか一項に記載の小売店ネットワーク。
- 前記中央サーバーが、前記顧客に対して後で実施される毒物試験で検出される毒物レベルと比較するために、検出済み毒物レベルを保存する、請求項1〜4のいずれか一項に記載の小売店ネットワーク。
- 前記比較が、前記小売店ネットワーク中の二つの異なる個々の小売店で検出された毒物レベル間の比較である、請求項5に記載の小売店ネットワーク。
- 前記毒物試験ステーションが顧客の電子喫煙装置用のインターフェースを備え、前記表示装置が、前記顧客の電子喫煙装置からの使用データを、検出された前記毒物レベルとともに表示するように構成されている、請求項1〜6のいずれか一項に記載の小売店ネットワーク。
- 前記顧客情報が、前記顧客の喫煙履歴、職業、ライフスタイル、自宅所在地、勤務地、健康状態および食事のうちの一つ以上についての情報を含む、請求項1〜7のいずれか一項に記載の小売店ネットワーク。
- 前記処理装置が、前記顧客に対して匿名の顧客識別子を生成するように構成されていて、識別顧客情報が前記匿名の顧客識別子とともに第一のデータベースに保存され、非識別顧客情報および検出済み毒物レベルが前記匿名の顧客識別子とともに第二のデータベースに保存される、請求項7に記載の小売店舗ネットワーク。
- 禁煙を補助する方法であって、
少なくとも二つの小売店のネットワークの一部を形成する小売店で、顧客の毒物のレベルを測定することと、
中央サーバーに保存されたデータベースとの間でデータを送受信することであって、 そのデータが前記測定された毒物レベルに関するデータを含むことと、
前記顧客に前記測定された毒物レベルを表示および説明することと、
前記顧客に加熱式たばこ製品または電子喫煙装置を提供することと、
前記加熱式たばこ製品または電子喫煙装置の一定期間の使用後に、前記顧客の前記毒物の新しいレベルを測定することと、
中央サーバーに保存されたデータベースとの間でデータを送受信することであって、 そのデータが前記測定された毒物レベルに関するデータを含むことと、毒物の前記新しいレベルを前記顧客に表示することと、を含む方法。 - 前記毒物の新しいレベルを測定する工程が、少なくとも二つの小売店の前記ネットワーク中の、前記第一の小売店とは異なる小売店で実施される、請求項10に記載の禁煙を補助する方法。
- 前記顧客に毒物の前記新しいレベルを表示する工程が、毒物の前記新しいレベルと以前に測定された毒物のレベルとの比較を表示することを含む、請求項10または請求項11に記載の禁煙を補助する方法。
- 前記毒物レベルを表示する工程、または毒物の前記新しいレベルを表示する工程のいずれかが、毒物の前記それぞれのレベルと 集団内の前記毒物の平均レベルとの比較を表示することを含む、請求項10〜12のいずれか一項に記載の禁煙を補助する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18192105.7 | 2018-08-31 | ||
EP18192105 | 2018-08-31 | ||
PCT/EP2019/073154 WO2020043857A1 (en) | 2018-08-31 | 2019-08-29 | System and method for promoting a change in consumer smoking habits |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021534489A true JP2021534489A (ja) | 2021-12-09 |
JPWO2020043857A5 JPWO2020043857A5 (ja) | 2022-09-06 |
JP7526162B2 JP7526162B2 (ja) | 2024-07-31 |
Family
ID=63490250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021507470A Active JP7526162B2 (ja) | 2018-08-31 | 2019-08-29 | 消費者の喫煙習慣の変化を促進するためのシステムおよび方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210313029A1 (ja) |
EP (1) | EP3844701A1 (ja) |
JP (1) | JP7526162B2 (ja) |
KR (1) | KR20210054530A (ja) |
CN (1) | CN112534460A (ja) |
WO (1) | WO2020043857A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11908583B2 (en) * | 2022-05-02 | 2024-02-20 | Kpn Innovations, Llc. | Apparatus and method for determining toxic load quantifiers |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005070953A (ja) * | 2003-08-21 | 2005-03-17 | Riso Kagaku Corp | 禁煙支援装置 |
JP2010026748A (ja) * | 2008-07-18 | 2010-02-04 | Sharp Corp | コンテンツ生成装置、サーバ装置、及びコンテンツ生成システム |
US20150064672A1 (en) * | 2013-09-05 | 2015-03-05 | Matthew Bars | Systems and methods for treatment of substance addiction |
JP6339298B1 (ja) * | 2017-04-20 | 2018-06-06 | 株式会社キュア・アップ | 禁煙患者のためのプログラム、装置、システム及び方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908301A (en) * | 1996-12-05 | 1999-06-01 | Lutz; Raymond | Method and device for modifying behavior |
GB2407165B (en) * | 2003-10-17 | 2008-04-30 | Micro Medical Ltd | Apparatus for measuring carbon monxide on a person's breath |
CN102018284A (zh) * | 2010-11-10 | 2011-04-20 | 高思 | 植物养肺止咳祛痰平喘自然香气功能香烟 |
US10517530B2 (en) * | 2012-08-28 | 2019-12-31 | Juul Labs, Inc. | Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances |
US20140060552A1 (en) * | 2012-08-28 | 2014-03-06 | Ploom, Inc. | Methods and devices for delivery and monitoring of tobacco, nicotine, or other substances |
CA2939937A1 (en) * | 2014-03-04 | 2015-09-11 | University Of Florida Research Foundation | Medication adherence monitoring device |
US10206572B1 (en) * | 2017-10-10 | 2019-02-19 | Carrot, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
WO2016164484A1 (en) * | 2015-04-07 | 2016-10-13 | Carrot Sense, Inc. | Systems and methods for quantification of, and prediction of smoking behavior |
DE102015007344B4 (de) * | 2015-06-12 | 2018-08-16 | Dräger Safety AG & Co. KGaA | Vorrichtung zur Bestimmung des Anteils unerlaubter Substanzen im Atem einer Person |
CN205624450U (zh) * | 2016-01-04 | 2016-10-12 | 刘婕 | 一种智能芯片烟嘴 |
CN109414065B (zh) * | 2017-04-01 | 2023-01-20 | 卓尔悦欧洲控股有限公司 | 电子烟控制系统、方法、电子烟及可穿戴电子设备 |
CN107278126A (zh) * | 2017-05-18 | 2017-10-20 | 惠州市吉瑞科技有限公司深圳分公司 | 电子烟的控制方法及电子烟 |
US10856577B2 (en) * | 2017-09-20 | 2020-12-08 | Rai Strategic Holdings, Inc. | Product use and behavior monitoring instrument |
US11209417B2 (en) * | 2017-10-12 | 2021-12-28 | Carrot, Inc. | Breath sensor apparatus and methods of use |
CN107997239A (zh) * | 2017-12-13 | 2018-05-08 | 惠州市吉瑞科技有限公司深圳分公司 | 气溶胶发生装置及其控制方法、应用于气溶胶发生装置的微处理器 |
EP4143838A1 (en) * | 2020-04-30 | 2023-03-08 | McNeil AB | Biomarker based nicotine replacement therapy |
-
2019
- 2019-08-29 WO PCT/EP2019/073154 patent/WO2020043857A1/en unknown
- 2019-08-29 KR KR1020217008392A patent/KR20210054530A/ko unknown
- 2019-08-29 US US17/270,199 patent/US20210313029A1/en active Pending
- 2019-08-29 CN CN201980052278.4A patent/CN112534460A/zh active Pending
- 2019-08-29 JP JP2021507470A patent/JP7526162B2/ja active Active
- 2019-08-29 EP EP19759599.4A patent/EP3844701A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005070953A (ja) * | 2003-08-21 | 2005-03-17 | Riso Kagaku Corp | 禁煙支援装置 |
JP2010026748A (ja) * | 2008-07-18 | 2010-02-04 | Sharp Corp | コンテンツ生成装置、サーバ装置、及びコンテンツ生成システム |
US20150064672A1 (en) * | 2013-09-05 | 2015-03-05 | Matthew Bars | Systems and methods for treatment of substance addiction |
JP6339298B1 (ja) * | 2017-04-20 | 2018-06-06 | 株式会社キュア・アップ | 禁煙患者のためのプログラム、装置、システム及び方法 |
WO2018193592A1 (ja) * | 2017-04-20 | 2018-10-25 | 株式会社キュア・アップ | 禁煙患者のためのプログラム、装置、システム及び方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112534460A (zh) | 2021-03-19 |
WO2020043857A1 (en) | 2020-03-05 |
KR20210054530A (ko) | 2021-05-13 |
EP3844701A1 (en) | 2021-07-07 |
JP7526162B2 (ja) | 2024-07-31 |
US20210313029A1 (en) | 2021-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shahab et al. | Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study | |
Marian et al. | Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies | |
Gomez et al. | Affective and physiological responses to environmental noises and music | |
CA3115197C (en) | Systems and methods for quantification of, and prediction of smoking behavior | |
Dahms et al. | Passive smoking: effects on bronchial asthma | |
Haddock et al. | Tobacco use among firefighters in the central United States | |
Soule et al. | Waterpipe tobacco-smoking: a new smoking epidemic among the young? | |
Drehmer et al. | Thirdhand smoke beliefs of parents | |
Watson et al. | Smoking behavior and exposure: results of a menthol cigarette cross-over study | |
Johansson et al. | Capsaicin inhalation test for identification of sensory hyperreactivity | |
Veilleux et al. | Predictors and sequelae of smoking topography over the course of a single cigarette in adolescent light smokers | |
Brożek et al. | Acute respiratory responses to the use of e-cigarette: an intervention study | |
Dicpinigaitis et al. | Effect of electronic cigarette use on the urge-to-cough sensation | |
Kotlyar et al. | Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge | |
Shadel et al. | Scripted imagery manipulations and smoking cue reactivity in a clinical sample of self-quitters. | |
JP7526162B2 (ja) | 消費者の喫煙習慣の変化を促進するためのシステムおよび方法 | |
Orain-Pelissolo et al. | Lack of startle modulation by smoking cues in smokers | |
Gautam et al. | Prevalence and predictors of waterpipe smoking cessation among young adults in the US: findings from a population-based study | |
Rosewich et al. | Early impact of smoking on lung function, health, and well‐being in adolescents | |
Urch et al. | Does suggestibility modify acute reactions to passive cigarette smoke exposure? | |
Ojima et al. | Necessity and readiness for smoking cessation intervention in dental clinics in Japan | |
Appleton et al. | Effect of cigarette design on biomarkers of exposure, puffing topography and respiratory parameters | |
Sergio et al. | Effects of smoking and physical activity on the pulmonary function of young university nursing students in Cáceres (Spain) | |
Schneider et al. | The effect of acute exercise on smoking topography: No evidence for cutting down one puff at a time | |
Ernstgård et al. | Acute effects of exposure to vapours of standard and dearomatized white spirits in humans. 2. Irritation and inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220829 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220829 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230907 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230911 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231211 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240524 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240620 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240719 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7526162 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |